{
  "id": 11286322,
  "title": "Pelthos Therapeutics elects directors and approves new equity plan at annual meeting",
  "url": "https://urgent.news/2026/10/01/pelthos-therapeutics-elects-directors-and-approves-new-equity-plan-at",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-01T21:41:26.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/sec-filings/pelthos-therapeutics-elects-directors-and-approves-new-equity-plan-at-annual-meeting-93CH-4928555"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pelthos Therapeutics Inc. held its 2026 Annual Meeting of Stockholders on Monday, where stockholders voted on three proposals, including the election of directors, the ratification of the company’s independent auditor, and the approval of a new equity incentive plan. All eight nominees for the board of directors were elected to serve until the 2027 Annual Meeting or until successors are elected and qualified. The Pelthos Therapeutics Inc. 2026 Equity Incentive Plan, which replaces the company’s 2023 Equity Incentive Plan, was also approved by the stockholders. Despite recent volatility, InvestingPro analysis suggests the stock appears undervalued at current levels, placing it among opportunities on the platform’s Most Undervalued list.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}